Register Financial Advisors LLC Has $3.63 Million Position in Enovix Corporation $ENVX

Register Financial Advisors LLC boosted its holdings in Enovix Corporation (NASDAQ:ENVX) by 40.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 364,000 shares of the company’s stock after buying an additional 104,164 shares during the quarter. Enovix makes up approximately 1.4% of Register Financial Advisors LLC’s investment portfolio, making the stock its 14th largest position. Register Financial Advisors LLC owned 0.19% of Enovix worth $3,629,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Y Intercept Hong Kong Ltd bought a new stake in shares of Enovix in the 2nd quarter valued at about $3,612,000. Perennial Investment Advisors LLC lifted its stake in shares of Enovix by 50.2% in the 2nd quarter. Perennial Investment Advisors LLC now owns 366,100 shares of the company’s stock valued at $3,785,000 after purchasing an additional 122,278 shares during the period. XTX Topco Ltd bought a new position in shares of Enovix during the 2nd quarter worth approximately $1,107,000. Baird Financial Group Inc. lifted its position in shares of Enovix by 24.0% during the 2nd quarter. Baird Financial Group Inc. now owns 721,930 shares of the company’s stock valued at $7,465,000 after acquiring an additional 139,617 shares during the period. Finally, Sonora Investment Management Group LLC grew its stake in shares of Enovix by 27.5% in the 2nd quarter. Sonora Investment Management Group LLC now owns 413,676 shares of the company’s stock valued at $4,277,000 after buying an additional 89,227 shares during the period. 50.92% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Oppenheimer set a $24.00 price objective on Enovix in a report on Thursday, November 6th. Canaccord Genuity Group dropped their price target on shares of Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. Cantor Fitzgerald decreased their price target on Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Northland Securities set a $16.00 target price on Enovix in a research note on Monday, November 17th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Enovix in a research note on Monday, December 29th. Five research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $17.50.

Enovix Stock Performance

NASDAQ ENVX opened at $7.39 on Wednesday. The company’s 50 day simple moving average is $7.98 and its two-hundred day simple moving average is $10.22. The stock has a market capitalization of $1.59 billion, a PE ratio of -9.12 and a beta of 2.13. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47. Enovix Corporation has a 1 year low of $5.27 and a 1 year high of $16.49.

Enovix (NASDAQ:ENVX) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02. The firm had revenue of $7.99 million for the quarter, compared to analysts’ expectations of $7.94 million. Enovix had a negative return on equity of 61.78% and a negative net margin of 525.93%.The company’s revenue was up 86.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.17) EPS. Enovix has set its Q4 2025 guidance at -0.200–0.160 EPS. Analysts predict that Enovix Corporation will post -1.01 earnings per share for the current fiscal year.

Enovix Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.